Back
U.S.-South Africa Program for Collaborative Biomedical Research Phase 3 (HIV/AIDS) (R01 Clinical Trial Optional)
Due: Mar 12, 2025
$400,000
Other Eligible Applicants include the following:
- Non-domestic (non-U.S.) Entities (Foreign Organizations); See funding opportunity for eligibility criteria. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.